Collectively, these specific findings imply that the inhibitory effects of ANXA1 on ACD-induced chronic itch might be associated with reducing IL-17-mediated astrocyte activation and TfR1-caused iron accumulation in the dorsal horn of the spinal cord. This evidence concerns the gene TFRC and granular corneal dystrophy type II.